Dodge & Cox Buys 557,175 Shares of Humana Inc. $HUM

Key Points

• Dodge & Cox has increased its stake in Humana Inc. by 5.5%, owning 10,755,215 shares worth approximately $2.85 billion as of the latest SEC filing.
• Humana's recent quarterly earnings missed expectations, reporting $6.27 earnings per share compared to the consensus estimate of $6.32.
• The company announced a quarterly dividend of $0.885 per share, with a payout ratio of 27.17%, reflecting a 1.2% annual yield.

Dodge & Cox grew its stake in Humana Inc. (NYSE:HUM - Free Report) by 5.5% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 10,755,215 shares of the insurance provider's stock after purchasing an additional 557,175 shares during the quarter. Humana makes up about 1.6% of Dodge & Cox's holdings, making the stock its 21st largest position. Dodge & Cox owned approximately 8.91% of Humana worth $2,845,830,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors also recently modified their holdings of HUM. Cary Street Partners Investment Advisory LLC increased its position in shares of Humana by 63.9% during the first quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider's stock valued at $31,000 after acquiring an additional 46 shares during the last quarter. Riverview Trust Co purchased a new stake in shares of Humana during the first quarter valued at approximately $34,000. Garde Capital Inc. purchased a new stake in shares of Humana during the first quarter valued at approximately $36,000. Zions Bancorporation National Association UT purchased a new stake in shares of Humana during the first quarter valued at approximately $37,000. Finally, Whipplewood Advisors LLC increased its position in shares of Humana by 639.1% during the first quarter. Whipplewood Advisors LLC now owns 170 shares of the insurance provider's stock valued at $45,000 after acquiring an additional 147 shares during the last quarter. Institutional investors own 92.38% of the company's stock.

Analyst Ratings Changes

HUM has been the subject of a number of research analyst reports. Truist Financial decreased their price target on Humana from $280.00 to $260.00 and set a "hold" rating for the company in a research report on Wednesday, July 16th. Raymond James Financial raised Humana from a "market perform" rating to an "outperform" rating and set a $315.00 target price for the company in a research report on Thursday, May 1st. Morgan Stanley decreased their target price on Humana from $290.00 to $277.00 and set an "equal weight" rating for the company in a research report on Thursday, July 31st. Wells Fargo & Company decreased their target price on Humana from $348.00 to $344.00 and set an "overweight" rating for the company in a research report on Thursday, August 14th. Finally, Cantor Fitzgerald reissued a "neutral" rating and issued a $290.00 target price on shares of Humana in a research report on Thursday, May 1st. Seven analysts have rated the stock with a Buy rating and sixteen have issued a Hold rating to the company. According to data from MarketBeat, Humana currently has an average rating of "Hold" and an average target price of $283.29.

Humana Price Performance

Shares of NYSE HUM opened at $300.0120 on Friday. The stock has a market cap of $36.08 billion, a PE ratio of 23.02, a price-to-earnings-growth ratio of 1.73 and a beta of 0.44. Humana Inc. has a fifty-two week low of $206.87 and a fifty-two week high of $382.72. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.95 and a current ratio of 1.95. The stock has a fifty day moving average of $248.58 and a 200-day moving average of $253.73.

Humana (NYSE:HUM - Get Free Report) last announced its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share for the quarter, missing the consensus estimate of $6.32 by ($0.05). The company had revenue of $32.39 billion during the quarter, compared to analysts' expectations of $31.85 billion. Humana had a net margin of 1.28% and a return on equity of 13.67%. Humana's revenue for the quarter was up 9.6% compared to the same quarter last year. During the same quarter last year, the firm posted $6.96 earnings per share. Humana has set its FY 2025 guidance at 17.000- EPS. Equities research analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be paid a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, September 26th. This represents a $3.54 annualized dividend and a yield of 1.2%. Humana's dividend payout ratio (DPR) is currently 27.17%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.